Trial · NCT07904286
Sensory Neurography and S2PD After Digital Nerve Injury
NCT07904286, Recruiting, Cecilia Mellstrand Navarro
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Sensory Neurography and S2PD After Digital Nerve Injury. Trials, record NCT07904286. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07904286
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Sensory Neurography and S2PD After Digital Nerve Injury
- NCT number
- NCT07904286
- Status
- Recruiting
- Enrollment
- 60 participants, estimated
- Lead sponsor
- Cecilia Mellstrand Navarro
- Conditions
- Digital Nerve Injury, Sensory Neurography, S2PD
- Interventions
- Sensory neurography, Static two point discrimination test, S2PD
- First posted
- 2026-10-29
- Last updated
- 2026-10-29
Source ClinicalTrials.gov
Registered outcomes9
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Is there a correlation between the amplitude of the sensory nerve action potential and S2PD? | Participant assessments will be conducted during a single session lasting approximately 60 minutes | A potential correlation between the sensory nerve action potential amplitude (microvoltage) measured with sensory neurography and S2PD (in millimeters) measured with a discriminator, will be analysed with test for correlation and presented as a value between -1 and 1 |
| Primary | Is there a correlation between sensory nerve action potential area and S2PD? | Participant assessments will be conducted during a single session lasting approximately 60 minutes | A potential correlation between the sensory nerve action potential area (milliseconds\*microvoltage) measured with sensory neurography and S2PD (in millimeters) measured with a discriminator, will be analysed with test for correlation and presented as a value between -1 and 1 |
| Secondary | Does a certain value of S2PD correspond to a specific (percentage) value of the amplitude or area of the action potential? | Participant assessments will be conducted during a single session lasting approximately 60 minutes | We will evaluate the correlation between S2PD (in 1 mm steps) and the percentages of sensory neurography amplitude and area of the injured nerve. |
| Secondary | How does age affect the potential correlation between sensory neurography measures (amplitude and area) and S2PD? | Participant assessments will be conducted during a single session lasting approximately 60 minutes | A regression analysis will be used to evaluate what impact age (years) has on primary outcomes. |
| Secondary | How does participants' sex affect the potential correlation between sensory neurography measures (amplitude and area) and S2PD? | Participant assessments will be conducted during a single session lasting approximately 60 minutes | A regression analysis will be used to evaluate what impact participants' sex (male or female) has on primary outcomes. |
| Secondary | How does smoking affect the potential correlation between sensory neurography measures (amplitude and area) and S2PD? | Participant assessments will be conducted during a single session lasting approximately 60 minutes | A regression analysis will be used to evaluate what impact smoking (yes or no) has on primary outcomes. |
| Secondary | How does the type of injured nerve affect the potential correlation between sensory neurography measures (amplitude and area) and S2PD? | Participant assessments will be conducted during a single session lasting approximately 60 minutes | A regression analysis will be used to evaluate what impact type of injured nerve (digital nerves to second, third or radial side of the fourth finger) has on primary outcomes. |
| Secondary | How does time from injury affect the potential correlation between sensory neurography measures (amplitude and area) and S2PD? | Participant assessments will be conducted during a single session lasting approximately 60 minutes | A regression analysis will be used to evaluate what impact time from injury (in years) has on primary outcomes. |
| Secondary | How does the level of injury affect the potential correlation between sensory neurography measures (amplitude and area) and S2PD? | Participant assessments will be conducted during a single session lasting approximately 60 minutes | A regression analysis will be used to evaluate what impact level of injury (proximal or middle phalanx) has on primary outcomes. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers3
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07904286
GET https://conductscience.org/api/trials/v1/NCT07904286/registered